Immunotherapy drug a 'gamechanger' for head and neck cancer

By on
nivolumab cancer treatment

Nivolumab has been found to extend lives of relapsed patients who had run out of therapy options. An immunotherapy drug hailed as a potential gamechanger in the treatment of cancer could soon offer new hope to patients with currently untreatable forms of the disease.